D. Toledo

发表

Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3

D. Alonso, V. Segatori, M. Guthmann, 2013, Front. Immun..

ARandomized,Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in AdvancedNon–Small Cell LungCancer Patients

T. Crombet, E. Santiesteban, Yoanna I. Flores, 2014 .

Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody1

R. Pérez, A. M. Hernández, A. Macías, 2008, The Journal of Immunology.

Immunized with an Anti-Idiotype Antibody Non-Small Cell Lung Cancer Patients against NeuGcGM 3 Ganglioside Elicited in Characterization of the Antibody Response

R. Pérez, A. M. Hernández, A. Macías, 2008 .

1E10 anti-idiotype vaccine in non-small cell lung cancer: Experience in stage IIIb/IV patients.

M. Gabri, E. Santiesteban, A. de la Torre, 2007, Cancer biology & therapy.

A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients

T. Crombet, E. Santiesteban, A. de la Torre, 2014, Clinical Cancer Research.

advanced non-small-cell-lung cancer patients racotumomab-alum vaccine as switch maintenance therapy in A randomized , multicenter , placebo-controlled clinical trial of

T. Crombet, E. Santiesteban, Yoanna I. Flores, 2014 .

NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical Trial

L. E. Fernández, A. de la Torre, C. Viada, 2012, Breast cancer : basic and clinical research.

Evaluation of nimotuzumab Fab2 as an optical imaging agent in EGFR positive cancers

H. Fonge, A. Casacó, C. Geyer, 2023, Scientific reports.

Coatsome-replicon vehicles: Self-replicating RNA vaccines against infectious diseases.

K. McCullough, T. Ebensen, K. Schulze, 2023, Nanomedicine : nanotechnology, biology, and medicine.